Pell Bio-Med Technology Co., Ltd. (TPE:6949)
Taiwan · Delayed Price · Currency is TWD 355.00
+0.50 (0.14%)
Dec 23, 2025, 1:30 PM CST
Pell Bio-Med Technology Market Cap
Pell Bio-Med Technology has a market cap or net worth of 20.79 billion as of December 23, 2025. Its market cap has increased by 302.12% in one year.
Market Cap
20.79B
Enterprise Value
20.59B
Revenue
29.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
355.00
Market Cap Chart
Since March 8, 2024, Pell Bio-Med Technology's market cap has increased from 5.56B to 20.79B, an increase of 274.25%. That is a compound annual growth rate of 108.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 20.79B | 340.32% |
| Dec 31, 2024 | 4.72B | -15.00% |
| Mar 8, 2024 | 5.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 248.14B |
| PharmaEssentia | 182.89B |
| Heron Neutron Medical | 85.13B |
| Lotus Pharmaceutical | 74.42B |
| Bora Pharmaceuticals Co., LTD. | 62.46B |
| Lin BioScience | 33.67B |
| Lumosa Therapeutics | 30.91B |
| Center Laboratories | 28.37B |